Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688266 Suzhou Zelgen Biopharmaceuticals Co Ltd SHSE:688266
67 GF Score
Price ¥140.00
GF Value ¥216.30
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Suzhou Zelgen Biopharmaceuticals Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:688266
67GF Score
Suzhou Zelgen Biopharmaceuticals Co Ltd SHSE:688266
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Overvalued in 2026?

Based on GuruFocus' analysis, Suzhou Zelgen Biopharmaceuticals Co stock appears to be undervalued. The current stock price of ¥140.00 is trading 35.3% below its estimated GF Value™ of ¥216.30. GuruFocus considers Suzhou Zelgen Biopharmaceuticals Co to be Significantly Undervalued.

Key valuation signals for SHSE:688266:

  • FFO:
  • GF Value™: ¥216.30 vs. price of ¥140.00 (35.3% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688266 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Suzhou Zelgen Biopharmaceuticals Co Business Description

Address No.209 Chenfeng Road, Yushan Town, Jiangsu Province, Kunshan, CHN
Suzhou Zelgen Biopharmaceuticals Co Ltd is engaged in research and development of new chemical and biological drugs for various therapeutic areas, including tumors, bleeding and blood diseases, and hepatobiliary diseases.
67GF Score

Get the complete analysis for SHSE:688266

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥140.00
Price
¥216.30
GF Value